We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+29.22%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$999B
AUM Growth
+$134B
Cap. Flow
-$3.54B
Cap. Flow %
-0.35%
Top 10 Hldgs %
32.24%
Holding
3,356
New
224
Increased
2,237
Reduced
645
Closed
116

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.1B
2
AAPL icon
Apple
AAPL
+$11.6B
3
AMZN icon
Amazon
AMZN
+$3.54B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.07B
5
KEYS icon
Keysight
KEYS
+$1.82B

Sector Composition

Rank Sector Weight
1 Technology 37.73%
2 Healthcare 11.3%
3 Financials 10.32%
4 Communication Services 9.66%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGON icon
426
CG Oncology
CGON
$5.95B
$270M 0.03%
3,805,010
+152,030
+4% +$9.94M
WM icon
427
Waste Management
WM
$82.7B
$269M 0.03%
1,208,590
+54,693
+5% +$12.2M
PCOR icon
428
Procore
PCOR
$7.49B
$269M 0.03%
6,622,309
+1,025,399
+18% +$50.7M
OC icon
429
Owens Corning
OC
$9.79B
$268M 0.03%
1,689,068
+165,239
+11% +$20.1M
IBP icon
430
Installed Building Products
IBP
$5.32B
$267M 0.03%
1,161,780
-268,222
-19% -$65.2M
BE icon
431
Bloom Energy
BE
$85B
$267M 0.03%
880,527
-1,285,522
-59% -$329M
VIK icon
432
Viking Holdings
VIK
$35.9B
$266M 0.03%
2,540,825
+129,200
+5% +$11.2M
RNR icon
433
RenaissanceRe
RNR
$13.5B
$265M 0.03%
837,007
+32,963
+4% +$9.91M
PBR icon
434
Petrobras
PBR
$131B
$265M 0.03%
16,370,145
+699,204
+4% +$13.7M
AMCR icon
435
Amcor
AMCR
$19.7B
$264M 0.03%
6,093,531
+129,087
+2% +$5.12M
WTS icon
436
Watts Water Technologies
WTS
$11.9B
$264M 0.03%
673,229
-195,525
-23% -$61M
PTGX icon
437
Protagonist Therapeutics
PTGX
$9.18B
$264M 0.03%
2,149,662
+484,165
+29% +$50.6M
SYRE icon
438
Spyre Therapeutics
SYRE
$7.56B
$263M 0.03%
2,960,855
+1,362,125
+85% +$99.4M
Q
439
Qnity Electronics Inc
Q
$26.1B
$262M 0.03%
1,607,105
-205,794
-11% -$30.3M
EW icon
440
Edwards Lifesciences
EW
$49.7B
$259M 0.03%
2,857,608
-1,233,360
-30% -$103M
ALGM icon
441
Allegro MicroSystems
ALGM
$6.85B
$258M 0.03%
3,710,288
+3,596,489
+3,160% +$168M
TTWO icon
442
Take-Two Interactive
TTWO
$37.7B
$258M 0.03%
1,032,529
+100,177
+11% +$22.1M
TRNO icon
443
Terreno Realty
TRNO
$7.2B
$257M 0.03%
3,969,299
+19,331
+0.5% +$1.26M
BABA icon
444
Alibaba
BABA
$273B
$256M 0.03%
2,667,285
-473,047
-15% -$59.3M
KRYS icon
445
Krystal Biotech
KRYS
$10.2B
$255M 0.03%
687,400
+202,326
+42% +$60.5M
ARM icon
446
Arm
ARM
$331B
$255M 0.03%
719,274
+225,409
+46% +$59.9M
SU icon
447
Suncor Energy
SU
$79.8B
$255M 0.03%
4,741,313
+280,817
+6% +$17.8M
WFG icon
448
West Fraser Timber
WFG
$5.61B
$254M 0.03%
3,757,506
+62,871
+2% +$4.1M
IONS icon
449
Ionis Pharmaceuticals
IONS
$7.4B
$253M 0.03%
3,184,500
+159,249
+5% +$12M
MOD icon
450
Modine Manufacturing
MOD
$10.5B
$252M 0.03%
944,797
-778,625
-45% -$205M

Similar funds

T. Rowe Price Associates's Q2 2026 Portfolio in Review

As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
  • T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
  • T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
  • T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
  • T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
  • T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.